Literature DB >> 27200808

Quality Of Life Assessments In Korean Patients With Rheumatoid Arthritis (Ra): An Analysis From The Phase Iii Trial To Evaluate Equivalence Of The Etanercept Biosimilar Hd203 And Enbrel® In Combination With Methotrexate (Mtx) In Patients With Ra; The Hera Study.

S C Bae1, S R Lee2, Y Ahn3.   

Abstract

Entities:  

Year:  2014        PMID： 27200808     DOI： 10.1016/j.jval.2014.08.2578

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  4 in total

Review 1.  Biosimilars in rheumatology: current perspectives and lessons learnt.

Authors:  Thomas Dörner; Jonathan Kay
Journal:  Nat Rev Rheumatol       Date:  2015-08-18       Impact factor: 20.543

Review 2.  Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence.

Authors:  Ira Jacobs; Danielle Petersel; Leah Isakov; Sadiq Lula; K Lea Sewell
Journal:  BioDrugs       Date:  2016-12       Impact factor: 5.807

Review 3.  Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence.

Authors:  Ira Jacobs; Danielle Petersel; Lesley G Shane; Chee-Keng Ng; Carol Kirchhoff; Gregory Finch; Sadiq Lula
Journal:  BioDrugs       Date:  2016-12       Impact factor: 5.807

Review 4.  Focus on biosimilar etanercept - bioequivalence and interchangeability.

Authors:  Fabrizio Cantini; Maurizio Benucci
Journal:  Biologics       Date:  2018-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.